Ondansetron Injection
Product Images NDC 55154-2877

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 55154-2877). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

3aafa187 Bacf 4de7 Ba5c 6b9bc41e372c 00

3aafa187 Bacf 4de7 Ba5c 6b9bc41e372c 00
The text describes Ondansetron Injection, which is used for intravenous (IV) or intramuscular (IM) injection. It comes in 5 single-dose vials, each containing 2 mL of a solution containing 4 mg of ondansetron. The solution also contains sodium chloride, citric acid, and sodium citrate as buffers. Storage conditions should be controlled to be 20° - 25° C to prevent damage to the product. The package is not child-resistant and intended only for institutional use. There are directions included in the product insert. The package is manufactured by WEST-WARD in Eatontown, New Jersey, and distributed by Cardinal Health in Dublin, Ohio. The given LOT # is XXXXXXXXXX and the EXP. DATE is XX/XX/XX.*
FDA Label Image

Chemical Structure (Image 02)

Chemical Structure (Image 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.